Literature DB >> 3840437

Mean time and first-pass metabolism.

D Brockmeier, J Ostrowski.   

Abstract

The theoretical principles are outlined for estimating the fraction of a drug undergoing first-pass metabolism using only the plasma levels found after a single oral dose. Data for 3 drugs are used to illustrate the method. It involves analysis of the parent drug and the metabolite formed during the first passage through the gut wall and liver and evaluation of their total mean times. The mean time characteristics of molsidomine, nortriptyline and propranolol are considered and they confirm the theoretically deduced dependency of the mean time of the parent drug and the metabolite. Whether the results are more precise than those obtained from comparison of areas after oral and intravenous administration is discussed. From the data presented it is clear that the mean time method depends on the scatter inherent in the data. In order to estimate the true first-pass effect, greater scatter requires an increased number of data pairs, i.e. subjects. If intravenous data are not available, however, the method described provides a rough but worthwhile estimate of the first pass effect.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3840437     DOI: 10.1007/bf00547367

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  10 in total

1.  Influence of route of administration on drug availability.

Authors:  M Rowland
Journal:  J Pharm Sci       Date:  1972-01       Impact factor: 3.534

Review 2.  Glucuronidation and disposition of drug glucuronides in patients with renal failure. A review.

Authors:  R K Verbeeck
Journal:  Drug Metab Dispos       Date:  1982 Jan-Feb       Impact factor: 3.922

3.  Influence of first-pass effect on availability of drugs on oral administration.

Authors:  M Gibaldi; R N Boyes; S Feldman
Journal:  J Pharm Sci       Date:  1971-09       Impact factor: 3.534

4.  A simple integrated method for drug and derived metabolite kinetics. An application of the statistical moment theory.

Authors:  K K Chan
Journal:  Drug Metab Dispos       Date:  1982 Sep-Oct       Impact factor: 3.922

5.  In vitro-in vivo correlation, a time scaling problem? Evaluation of mean times.

Authors:  D Brockmeier
Journal:  Arzneimittelforschung       Date:  1984

6.  Relationship between pharmacokinetics and pharmacodynamics of molsidomine and its metabolites in humans.

Authors:  T Meinertz; A Brandstätter; D Trenk; E Jähnchen; J Ostrowski; W Gärtner
Journal:  Am Heart J       Date:  1985-03       Impact factor: 4.749

7.  A standard approach to compiling clinical pharmacokinetic data.

Authors:  L B Sheiner; L Z Benet; L A Pagliaro
Journal:  J Pharmacokinet Biopharm       Date:  1981-02

8.  Pharmacokinetics of glucuronidation of propranolol following oral administration in humans.

Authors:  K K Midha; R M Roscoe; T W Wilson; J K Cooper; J C Loo; A Ho-Ngoc; I J McGilveray
Journal:  Biopharm Drug Dispos       Date:  1983 Oct-Dec       Impact factor: 1.627

9.  Determination of molsidomine in plasma by high-performance liquid column chromatography.

Authors:  D Dell; J Chamberlain
Journal:  J Chromatogr       Date:  1978-11-01

10.  First pass hydroxylation of nortriptyline: concentrations of parent drug and major metabolites in plasma.

Authors:  G Alván; O Borga; M Lind; L Palmér; B Siwers
Journal:  Eur J Clin Pharmacol       Date:  1977-03-11       Impact factor: 2.953

  10 in total
  4 in total

1.  The relevance of residence time theory to pharmacokinetics.

Authors:  M Weiss
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

Review 2.  Mean time parameters in pharmacokinetics. Definition, computation and clinical implications (Part II).

Authors:  P Veng-Pedersen
Journal:  Clin Pharmacokinet       Date:  1989-12       Impact factor: 6.447

3.  Effects of first-pass metabolism on metabolite mean residence time determination after oral administration of parent drug.

Authors:  K K Chan; M Gibaldi
Journal:  Pharm Res       Date:  1990-01       Impact factor: 4.200

4.  Metabolite residence time: influence of the first-pass effect.

Authors:  M Weiss
Journal:  Br J Clin Pharmacol       Date:  1986-07       Impact factor: 4.335

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.